Veeda Clinica Research

-3.03 % 1 M

About Veeda Clinica Research

A Comprehensive Overview of Price & Journey
Understanding Veeda Clinica Research Inception and Growth
SHOW MORE...

About Veeda Clinica Research

IPO Details, Price movement

trydukfiltyuo;ip

SHOW MORE...

Fundamentals

Market Cap (in cr.)
₹ 30239926080
P/E Ratio
1.57
P/B Ratio
2.85
Debt to Equity
0.00
ROE (%)
58.65
Book Value
168.67
Face Value
2.00
Total Shares
62999846
Category
Unlisted Shares
Unlisted CMP
₹ 0 / Share
Lot Size
0 Shares
52 Week High
₹0.00
52 Week Low
₹0.00
Depository
NSDL & CDSL
PAN Number
AACCC3633Q
ISIN Number
INE01HQ01026
CIN
U73100GJ2004PLC044023
Sector
Health Care

Financials

All values are INR Cr except per share value

P&L Statement 2023 2024
Revenue 223.93 296.15
Other Income 4.23 9.15
COGS 18.83 17.81
Gross Profit 209.33 287.49
Total Expense 164.02 223.93
EBIDTA 45.31 63.56
D&A 15.53 21.13
EBIT 29.78 42.43
Interest Expense 4.58 5.33
PBT 25.20 37.10
TAX 6.87 11.15
PAT 18.33 25.95
Diluted EPS 3.90 4.90
Basic EPS 3.91 4.91
Total income 228.16 305.30
ASSETS
CURRENT ASSETS 2023 2024
Cash and Cash Equivalents 57.72 33.32
Trade Payables 77.39 71.14
Inventory 6.99 4.90
Other Current Assets 163.03 153.47
Total Current Assets 305.13 262.83

NON CURRENT ASSETS 2023 2024
Plant Property and Equipment 77.71 107.17
Long Term Investment 165.13 213.15
Other Non Current Assets 48.67 77.34
Total Non Current Assets 291.51 397.66

Total Assets 596.64 660.49

CURRENT LIABILITES 2023 2024
TRADW Payable 21.48 19.19
Other Current Liab 67.20 77.21

NON CURRENTLIABILITIES 2023 2024
Other Non Current Liab 34.24 42.88

LIABILITIES
EQUITY 2023 2024
Share Capital 10.57 10.58
Other Equity 463.18 510.60
Total Equity 473.75 521.18

Total Liabilities & Equity 473.75 521.18

CASH FLOW STAT 2023 2024
Cash Flow from operating - - 12.73 75.06
Cash Flow from financing - - 172.10 8.15
Cash Flow from investing - - -141.83 -106.71
Net cash flow 0.00 0.00 43.00 -23.50

Revenue Growth
PAT Growth %
EPS Growth %
TOTAL ASSETS Growth %
QUICK RATIO Growth %
LONG TERM DEBT TO EQUITY RATIO Growth %
Shareholding Pattern
2026
Name Designation Share %
Basil Private Limited NA 35.52%
Bondway Investment Inc NA 20.45%
Sabre Partners AIF Trust NA 4.38%
Others NA 39.65%
Events
Name Date Details
No events available.
Promoters or Management
Name Designation Linkedin Profile
Nitin Deshmukh Chairman
Mahesh Bhalgat MD & CEO
Binoy Gardi Director

Frequently Asked Questions

1. How is the price of an unlisted share of Veeda Clinica Research determined?

Like any other financial product or commodity, the price of unlisted shares is discovered at the intersection of demand from buyers and supply from sellers of particular unlisted shares.

The two determinants of price are dynamic factors and keep changing constantly, hence share price tends to fluctuate constantly – every day, every minute.

2. How shares of Veeda Clinica Research are delivered and held?
3. What is the lock-in period of Veeda Clinica Research?
4. What is the minimum ticket size required to invest in Veeda Clinica Research?
5. How much Short-Term Capital Gain tax do I require to pay on Veeda Clinica Research ?
6. How much Long-Term Capital Gain tax do I require to pay on Veeda Clinica Research ?
7. How to check credit of Veeda Clinica Research Unlisted Shares Unlisted Shares/Pre-IPO shares?
8. How is valuation of Veeda Clinica Research Unlisted Shares Unlisted Shares/Pre-IPO shares decided?
9. Is investing in Veeda Clinica Research legal in India?
10. Is investing in Veeda Clinica Research safe?

Related News